Lv3
308 积分 2025-04-02 加入
Cancer incidence and mortality in China, 2024
19小时前
已完结
Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer
8天前
已完结
Positioning Zolbetuximab in HER2-Negative Advanced Gastric Cancer: A Practical Framework for Treatment Selection in the ICI Era
1个月前
已完结
Claudin 18.2 Targeting: A Pan-Cancer Perspective
1个月前
已关闭
Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma
1个月前
已关闭
Chinese guidelines for HER2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma (2025 Edition)
1个月前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
1个月前
已完结
Superiority of the 8th edition of the TNM staging system for predicting overall survival in gastric cancer: Comparative analysis of the 7th and 8th editions in a monoinstitutional cohort
1个月前
已完结
胃癌腹膜转移诊治中国专家共识（2023版）
2个月前
已完结
中国经肛腔镜手术专家共识及操作指南（2023版）
2个月前
已关闭
皖公网安备34019202002308
